Proposal Status/Commentary
USP posts the status of Revisions, Deferrals, Cancellations, and Commentary for each USP–NF and Supplement.
- Revisions are approved standards that will appear in the publication
- Deferrals are items that have been proposed in Pharmacopeial Forum (PF) but are not yet approved by an Expert Committee
- Cancellations are items that have been proposed in PF but have been canceled. Canceled items may be re-proposed in a future PF
- Commentary is a summary of comments received and the appropriate Expert Committee's responses in cases when proposals advance to official status without being re-published in PF
Revisions, Deferrals, and Cancellations generally are posted in advance of posting of the online USP–NF or Supplement. Commentary is posted at the time the online USP–NF or Supplement is posted.
Note: The Deferral and Cancellation lists replace the "Previous PF Proposals Still Pending" and "Canceled Proposals" lists that previously appeared in each PF.
USP 35–NF 30
Book
- Revisions (posted 29–Jul–2011)
- Deferrals (posted 29–Jul–2011)
- Cancellations (posted 29–Jul–2011)
- Commentary (posted 01–Nov–2011)
First Supplement
- Revisions (posted 29–Dec–2011)
- Deferrals (posted 29–Dec–2011)
- Cancellations (posted 29–Dec–2011)
- Commentary (posted 03–Feb–2012)
Second Supplement
- Revisions (posted 27–Apr–2012)
- Deferrals (posted 27–Apr–2012)
- Cancellations (posted 27–Apr–2012)
IRAs (Commentary only)
- IRAs in 37(2): No comments received for proposed IRAs in Pharmacopeial Forum 37(2)
- IRAs in 37(3): No comments received for proposed IRAs in Pharmacopeial Forum 37(3)
USP 34–NF 29
Book
- Revisions (posted 27–Aug–2010)
- Deferrals (posted 27–Aug–2010)
- Cancellations (posted 27–Aug–2010)
- Commentary (posted 01–Nov–2010)
First Supplement
- Revisions (posted 24–Nov–2010)
- Deferrals (posted 24–Nov–2010)
- Cancellations (posted 24–Nov–2010)
- Commentary (posted 01–Feb–2011)
Second Supplement
- Revisions (posted 01–Nov–2011)
- Deferrals (posted 29–Apr–2011)
- Cancellations (posted 29–Apr–2011)
- Commentary (posted 01–Jun–2011)
IRAs (Commentary only)
- IRAs in 36 (5) (posted 16–May–2011)
- IRAs in 36 (6) (posted 16–May–2011)
IRAs in 36(3) and 36(4): No commentary for Pharmacopeial Forum 36(3) and 36(4) because no IRAs became official in these PFs.
IRAs in 37(1): There were no proposed IRAs in Pharmacopeial Forum 37(1).
USP 33–NF 28 View
Book
- Revisions(A-C) (posted Apr–2010) D-N O-S T-Z
- Commentary (posted 01–Nov–2010)
First Supplement
Second Supplement
- Revisions (posted 30–Jun–2010) A-C D-N O-S T-Z
- Commentary (posted Jul–2010)
- IRAs (Commentary only)
- IRAs in PF 35(5) (posted 16–May–2011)
- IRAs in PF 36(1) (posted 16–May–2011)
IRAs in 35(6) and 36(2): No commentary for Pharmacopeial Forum 35(6) and 36(2) because no IRAs became official in these PFs.
USP 32–NF 27 View
Book
First Supplement
Second Supplement
IRAs (Commentary only)
- IRAs in 35(3) (revised 15–Apr–2009)
- IRAs in 35(4) (revised 11–Jun–2009)
- Heparin Sodium and Heparin Sodium Stage 2 Monograph Commentary
(Posted 05–Jan–2010)
USP 31–NF 26 View
Book
First Supplement
Second Supplement
- Revisions (published Apr–2008) A-C D-N O-S T-Z
- Commentary (published May–2008)
- Additional Commentary on <797> Revisions to USP 31-NF 26 Second Supplement (originally published Dec–2007)
IRAs (Commentary only)
- IRAs in 34(3) (revised 30–Jun–2008)
- IRAs in 34(4) (revised 30–Jun–2008)
- IRAs in 34(5) (revised 01–Aug–2008)
- IRAs in 34(6) (revised 31–Oct–2008)
- IRAs in 35(1): There is no Commentary for Pharmacopeial Forum 35(1) because no Interim Revision Announcements became official in this Pharmacopeial Forum.
- IRAs in 35(2) (revised 11–Feb–2009)
USP 30–NF 25 View
Book (Note that USP did not begin posting commentary on the USP website until Supplement 1 to USP 30–NF 25)
First Supplement
Second Supplement
IRAs (Commentary only)
- IRAs in 34(1) (revised 30–Jun–2008)
- IRAs in 34(2) (revised 30–Jun–2008)
Follow Us On: